|
US5733933A
(en)
*
|
1984-03-19 |
1998-03-31 |
The Picower Institute For Medical Research |
Methods and materials for the diagnosis and treatment of conditions such as stroke
|
|
US5801200A
(en)
*
|
1984-03-19 |
1998-09-01 |
The Picower Institute For Medical Research |
Methods and materials for the diagnosis and treatment of conditions such as stroke
|
|
US5869534A
(en)
*
|
1992-05-21 |
1999-02-09 |
The Picower Institute For Medical Research |
Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom
|
|
US5733524A
(en)
*
|
1984-03-19 |
1998-03-31 |
The Picower Institute For Medical Research |
Methods and materials for the diagnosis and treatment of conditions such as stroke
|
|
US5700447A
(en)
*
|
1992-05-21 |
1997-12-23 |
The Picowder Institute For Medical Research |
Methods and materials for the diagnosis and treatment of conditions such as stroke
|
|
EP0319144A1
(fr)
*
|
1987-11-06 |
1989-06-07 |
Asahi Kasei Kogyo Kabushiki Kaisha |
Absorbant de bêta-2-microglobuline
|
|
US5216127A
(en)
*
|
1987-11-20 |
1993-06-01 |
Kanegafuchi Kagaku Kogyo Kabushiki Kaisha |
Adsorbent for serum amyloid protein
|
|
DE3880647T2
(de)
*
|
1987-11-20 |
1993-11-18 |
Kanegafuchi Chemical Ind |
Sorbentmittel für Serum-Amyloid-Proteine.
|
|
CA1335361C
(fr)
*
|
1989-05-24 |
1995-04-25 |
Andrei Z. Budzynski |
Complexes diriges contre les thrombus et formes d'activateurs du plasminogene et de fragments de fibrine
|
|
US5180615A
(en)
*
|
1989-12-13 |
1993-01-19 |
W.R. Grace & Co.-Conn. |
Metallized bag for static protection of electronic components
|
|
US5591431A
(en)
*
|
1990-03-09 |
1997-01-07 |
G.D. Searle & Co. |
Enhancement of clot lysis
|
|
US5753624A
(en)
*
|
1990-04-27 |
1998-05-19 |
Milkhaus Laboratory, Inc. |
Materials and methods for treatment of plaquing disease
|
|
US5650418A
(en)
*
|
1990-06-04 |
1997-07-22 |
Therapy 2000 |
Therapeutic lysine salt composition and method of use
|
|
US5230996A
(en)
*
|
1990-06-04 |
1993-07-27 |
Therapy 2000 |
Use of ascorbate and tranexamic acid solution for organ and blood vessel treatment prior to transplantation
|
|
US5278189A
(en)
*
|
1990-06-04 |
1994-01-11 |
Rath Matthias W |
Prevention and treatment of occlusive cardiovascular disease with ascorbate and substances that inhibit the binding of lipoprotein (A)
|
|
US5780587A
(en)
*
|
1990-08-24 |
1998-07-14 |
President And Fellows Of Harvard College |
Compounds and methods for inhibiting β-protein filament formation and neurotoxicity
|
|
US5434050A
(en)
*
|
1991-08-13 |
1995-07-18 |
Regents Of The University Of Minnesota |
Labelled β-amyloid peptide and methods of screening for Alzheimer's disease
|
|
US5276059A
(en)
*
|
1992-07-10 |
1994-01-04 |
The United States Of America As Represented By The Department Of Health And Human Services |
Inhibition of diseases associated with amyloid formation
|
|
US5491129A
(en)
*
|
1992-07-30 |
1996-02-13 |
Yeda Research And Development Co. Ltd. |
Synthetic peptides derived from vitronectin and pharmaceutical compositions comprising them
|
|
US5605691A
(en)
*
|
1992-09-17 |
1997-02-25 |
Ophidian Pharmaceuticals, Inc. |
Immunologically active proteins from inclusion bodies
|
|
US5958883A
(en)
*
|
1992-09-23 |
1999-09-28 |
Board Of Regents Of The University Of Washington Office Of Technology |
Animal models of human amyloidoses
|
|
DE4242736A1
(de)
*
|
1992-12-17 |
1994-06-23 |
Behringwerke Ag |
Synthetische Peptide, Antikörper dagegen und ihre Verwendung
|
|
US5955343A
(en)
*
|
1992-12-28 |
1999-09-21 |
Massachusetts Institute Of Technology |
Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
|
|
US5449663A
(en)
*
|
1993-06-11 |
1995-09-12 |
Bicher; Haim I. |
Antineoplastic compositions
|
|
US6410598B1
(en)
*
|
1994-02-03 |
2002-06-25 |
Michael P. Vitek |
Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis
|
|
AU692237B2
(en)
*
|
1994-02-03 |
1998-06-04 |
Picower Institute For Medical Research, The |
Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis
|
|
US5786324A
(en)
*
|
1994-03-24 |
1998-07-28 |
Regents Of The University Of Minnesota |
Synthetic peptides with bactericidal activity and endotoxin neutralizing activity for gram negative bacteria and methods for their use
|
|
US5589154A
(en)
*
|
1994-11-22 |
1996-12-31 |
Rutgers, The State University Of New Jersey |
Methods for the prevention or treatment of vascular hemorrhaging and Alzheimer's disease
|
|
US6136548A
(en)
*
|
1994-11-22 |
2000-10-24 |
Rutgers, The State University Of New Jersey |
Methods for identifying useful T-PA mutant derivatives for treatment of vascular hemorrhaging
|
|
US5854204A
(en)
*
|
1995-03-14 |
1998-12-29 |
Praecis Pharmaceuticals, Inc. |
Aβ peptides that modulate β-amyloid aggregation
|
|
US5854215A
(en)
*
|
1995-03-14 |
1998-12-29 |
Praecis Pharmaceuticals Incorporated |
Modulators of β-amyloid peptide aggregation
|
|
US5817626A
(en)
*
|
1995-03-14 |
1998-10-06 |
Praecis Pharmaceuticals Incorporated |
Modulators of beta-amyloid peptide aggregation
|
|
US5948763A
(en)
*
|
1995-06-07 |
1999-09-07 |
New York University |
Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits
|
|
US6436969B1
(en)
*
|
1995-09-12 |
2002-08-20 |
Kansas University Medical Center Research Institute Inc. |
Dialysis solutions and methods
|
|
EP0882139A1
(fr)
*
|
1995-10-02 |
1998-12-09 |
Mohammed W. Katoot |
Polymeres biologiquement actifs
|
|
US5985242A
(en)
*
|
1995-10-27 |
1999-11-16 |
Praecis Pharmaceuticals, Inc. |
Modulators of β-amyloid peptide aggregation comprising D-amino acids
|
|
US6310046B1
(en)
*
|
1995-11-17 |
2001-10-30 |
The United States Of America As Represented By The Secretary Of The Army |
Sequestrin of Plasmodium falciparum
|
|
US6001331A
(en)
*
|
1996-01-24 |
1999-12-14 |
Warner-Lambert Company |
Method of imaging amyloid deposits
|
|
US5785187A
(en)
*
|
1996-04-29 |
1998-07-28 |
Lipman; Daniel |
Mechandising display assembly
|
|
US6034211A
(en)
*
|
1996-06-03 |
2000-03-07 |
Kelly; Jeffery W. |
β-sheet nucleating peptidomimetics
|
|
US6929807B1
(en)
*
|
1996-08-09 |
2005-08-16 |
Mannatech, Inc. |
Compositions of plant carbohydrates as dietary supplements
|
|
US6689275B1
(en)
*
|
1996-12-31 |
2004-02-10 |
Ajay Gupta |
Method and pharmaceutical composition for replacing iron losses in dialysis patients
|
|
US6372473B1
(en)
*
|
1997-05-28 |
2002-04-16 |
Human Genome Sciences, Inc. |
Tissue plasminogen activator-like protease
|
|
US20020122807A1
(en)
*
|
1998-07-07 |
2002-09-05 |
Dan Michael D. |
Antigen binding fragments, designated 4B5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
|
|
AU9125798A
(en)
*
|
1997-08-28 |
1999-03-16 |
University Of Washington |
Specific saccharide compositions and methods for treating alzheimer's disease and other amyloidoses
|
|
EP1032403B1
(fr)
*
|
1997-10-24 |
2012-05-02 |
John P. Blass |
Supplement nutritionnel pour personnes atteintes d'insuffisances du metabolisme cerebral
|
|
US6399314B1
(en)
*
|
1999-12-29 |
2002-06-04 |
American Cyanamid Company |
Methods of detection of amyloidogenic proteins
|
|
AU783144B2
(en)
*
|
2000-02-21 |
2005-09-29 |
H. Lundbeck A/S |
Novel method for down-regulation of amyloid
|
|
JP5025871B2
(ja)
*
|
2000-02-21 |
2012-09-12 |
エイチ．リュンドベック エイ／エス |
アミロイドの新規なダウン−レギュレート方法
|
|
EP1130031A1
(fr)
*
|
2000-02-25 |
2001-09-05 |
Universitair Medisch Centrum Utrecht |
Procédé pour inhiber l'angiogenèse à l'aide des molécules qui augmentent la formation de la plasmine ou qui prolongent son activité
|
|
AU2001247667A1
(en)
*
|
2000-03-21 |
2001-10-03 |
Research Foundation Of State University Of New York |
Adsorption of polyampholytes to charged surfaces and assays incorporating same
|
|
US7270800B2
(en)
*
|
2000-08-24 |
2007-09-18 |
University Of Pittsburgh |
Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
|
|
RU2324686C2
(ru)
*
|
2000-08-24 |
2008-05-20 |
Юнивесити Оф Питсбэг |
ПРОИЗВОДНЫЕ ТИОФЛАВИНА, СВЯЗЫВАЮЩИЕ АМИЛОИД, СПОСОБ ОБНАРУЖЕНИЯ in vivo ОТЛОЖЕНИЙ АМИЛОИДА И СПОСОБ РАСПОЗНАВАНИЯ БОЛЕЗНИ АЛЬЦГЕЙМЕРА
|
|
EP1186299A1
(fr)
*
|
2000-09-12 |
2002-03-13 |
Universitair Medisch Centrum Utrecht |
Diagnostic, prévention et/ou traitement d' athérosclérose, infections et perturbations du système immunitaire
|
|
EP1355664A4
(fr)
*
|
2001-01-04 |
2005-10-26 |
Vascular Biogenics Ltd |
Methodes faisant appel a des molecules associees a des plaques d'atherosclerose et compositions contenant lesdites molecules, destinees a la prevention et au traitement de l'atherosclerose
|
|
EP1414491A4
(fr)
*
|
2001-07-09 |
2005-07-06 |
Elan Pharm Inc |
Procedes inhibant la toxicite amyloide
|
|
JP2003024080A
(ja)
*
|
2001-07-19 |
2003-01-28 |
Univ Tokyo |
ｐ５３依存性アポトーシス誘導タンパク質、およびアポトーシス調節剤のスクリーニング方法
|
|
WO2003073106A2
(fr)
*
|
2002-02-28 |
2003-09-04 |
Microsens Biophage Limited |
Liaison de formes pathologiques de proteines prion
|
|
EP1507543A4
(fr)
*
|
2002-05-09 |
2006-07-26 |
Cambridgemed Inc |
Composition pharmaceutique destinee au traitement de plaies et contenant du plasma ou du serum sanguins
|
|
EP1380290A1
(fr)
*
|
2002-07-09 |
2004-01-14 |
Universitair Medisch Centrum Utrecht |
La voie de la structure cross-béta et sa pertinence thérapeutique
|
|
US20070003552A1
(en)
*
|
2002-07-09 |
2007-01-04 |
Gebbink Martijn F B |
Cross-beta structure comprising amyloid binding proteins and methods for detection of the cross-beta structure, for modulating cross-beta structures fibril formation and for modulating cross-beta structure-mediated toxicity and method for interfering with blood coagulation
|
|
US20040143093A1
(en)
*
|
2002-07-11 |
2004-07-22 |
Ralph Zahn |
Method for inducing a conformational transition in proteins, such as pathogenic/infectious proteins, and their use
|
|
US20050142611A1
(en)
*
|
2002-09-30 |
2005-06-30 |
Auburn University |
Method of isolation and self-assembly of small protein particles from blood and other biological materials
|
|
US7470667B2
(en)
*
|
2002-12-05 |
2008-12-30 |
Medgenn (Hong Kong) Ltd |
Methods of treating cancer using a modified endostatin protein
|
|
WO2004073651A2
(fr)
*
|
2003-02-18 |
2004-09-02 |
The Ohio State University Research Foundation |
Identification d'inhibiteurs de la fibrillisation proteique intracellulaire
|
|
WO2006091038A1
(fr)
*
|
2005-02-25 |
2006-08-31 |
Medigenes Co., Ltd. |
Composition pharmaceutique pour le traitement de la dystrophie corneenne d'avellino comporte du plasma sanguin et ou du serum
|
|
EP1704867A1
(fr)
*
|
2005-03-18 |
2006-09-27 |
Crossbeta Biosciences B.V. |
Des Structures cross-Beta sur des microorganismes
|
|
WO2007008073A2
(fr)
*
|
2005-07-13 |
2007-01-18 |
Crossbeta Biosciences B.V. |
Methodes de determination de l'effet d'un traitement sur la teneur d'une proteine a structure croisee $g(b); selection des traitements et leurs utilisations
|
|
AU2006267176A1
(en)
*
|
2005-07-13 |
2007-01-18 |
Crossbeta Biosciences B.V. |
Cross-beta structure binding compounds
|
|
US8114832B2
(en)
*
|
2005-07-13 |
2012-02-14 |
Crossbeta Biosciences B.V. |
Method for detecting and/or removing a protein comprising a cross-beta structure from a pharmaceutical composition
|
|
US8543424B2
(en)
*
|
2005-12-30 |
2013-09-24 |
Darryl Mark Hunsaker |
Vehicle insurance status display system
|